Matthew Sims, Charles Berenson, Stuart Cohen, Elaine Wang, Elizabeth Hohmann, Richard Nathan, . . . Lisa Von Moltke. (2023). Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI. Cambridge University Press.
Chicago Style (17th ed.) CitationMatthew Sims, et al. Integrated Safety Analysis of Phase 3 Studies for Investigational Microbiome Therapeutic, SER-109, in Recurrent CDI. Cambridge University Press, 2023.
MLA (9th ed.) CitationMatthew Sims, et al. Integrated Safety Analysis of Phase 3 Studies for Investigational Microbiome Therapeutic, SER-109, in Recurrent CDI. Cambridge University Press, 2023.
Warning: These citations may not always be 100% accurate.